ARVEN ILAC SAN TIC A.S.

ARVEN ILAC SAN TIC A.S. is a Turkish pharmaceutical company established in 2013. The company is actively involved in the research and development, production, and marketing of pharmaceutical products. Its mission is to contribute to human health by developing and manufacturing high-quality and effective medicines.

ARVEN ILAC SAN TIC A.S. is a factory (manufacturer). The company operates its own dedicated production facilities for pharmaceutical manufacturing.

ARVEN ILAC SAN TIC A.S. (Arven Pharmaceuticals) produces and sells a range of pharmaceutical products, with a significant focus on biosimilars and high-tech specialty pharmaceuticals.

Their product portfolio covers various therapeutic areas, including:

Oncology

Hematology

Rheumatology

Nephrology

Immunology

Ophthalmology

Gastroenterology

Neurology

Endocrinology

Dermatology

Specific examples of biosimilar products they manufacture or market include:

Arvenfliks (Infliximab biosimilar)

Arvencept (Etanercept biosimilar)

Arvenzumab (Trastuzumab biosimilar)

Arvenfil (Filgrastim biosimilar)

Arvensim (Adalimumab biosimilar)

Arvenriz (Rituximab biosimilar)

Arvenluc (Pegfilgrastim biosimilar)

Arvenmab (Bevacizumab biosimilar)

Arvenast (Denosumab biosimilar)

Arvenfoll (Follitropin alfa biosimilar)